Latest | F'cast | |
---|---|---|
Div Yield | 4.6% | 0.0% |
Div Cover | 2.4 | 3.0 |
Op Mrgn | 6.3% | 23.1% |
ROCE | 16.2% |
Latest | F'cast | |
---|---|---|
P/E | 9.1 | 8.6 |
PEG | n/a | 1.6 |
Pr/Revenue | 1.3 | 1.2 |
Pr/Book | 0.7 |
Latest | F'cast | |
---|---|---|
Revenue | 2.6% | 9.1% |
PBT | -71.3% | 709.6% |
EPS | -33.0% | 5.4% |
DPS | 5.0% | -16.1% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-18 | 118.21 | 22.80 | 4.54p | 14.8 | n/a | -15% | 1.46p | 2.2% |
31-Dec-19 | 135.64 | 31.08 | 5.09p | 16.5 | 1.4 | +12% | 0.54p | 0.6% |
31-Dec-20 | 129.80 | 13.02 | 5.11p | 17.1 | n/a | 0% | 1.61p | 1.8% |
31-Dec-21 | 163.21 | 18.16 | 6.39p | 17.0 | 0.7 | +25% | 1.69p | 1.6% |
31-Dec-22 | 167.42 | 5.21 | 4.28p | 12.4 | n/a | -33% | 1.78p | 3.4% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-23 | 182.73 | 42.16 | 4.51p | 8.6 | 1.6 | +5% | 1.49p | 0.0% |
31-Dec-24 | 198.24 | 46.93 | 5.40p | 7.2 | 0.4 | +20% | 1.51p | 0.0% |
31-Dec-25 | 215.91 | 52.22 | 6.42p | 6.1 | 0.3 | +19% | 1.57p | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Total Voting Rights | 01-Dec-2023 | 12:23 | RNS |
Notification of Major Holdings | 09-Nov-2023 | 11:17 | RNS |
Appointment of Non-Executive Directors | 07-Nov-2023 | 07:00 | RNS |
Drug sales lead the way for Boots as revenues ri... | 31-Oct-2008 | The Scotsman |
Look ahead | 13-Sep-2006 | Times |
Look ahead | 12-May-2006 | Times |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 38.90p |
Change Today | -1.10p |
% Change | -2.75 % |
52 Week High | 71.80 |
52 Week Low | 34.50 |
Volume | 317,562 |
Shares Issued | 540.39m |
Market Cap | £210.21m |
Beta | 0.72 |
RiskGrade | 119 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 1 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 22-Jun-23 | 22-Dec-22 |
Paid | 18-Jul-23 | 19-Jan-23 |
Amount | 1.18p | 0.59p |
Time | Volume / Share Price |
16:35 | 40,056 @ 38.90p |
16:35 | 491 @ 38.90p |
16:35 | 1,091 @ 38.90p |
16:35 | 1,649 @ 38.90p |
16:35 | 2,012 @ 38.90p |
CEO | Peter Butterfield |
CFO | Andrew Franklin |
Chair | Jo Le Couilliard |
You are here: research